Direct LDL-C estimation in preschoolers: Practicable first step for FH screening

J Clin Lipidol. 2023 Mar-Apr;17(2):255-260. doi: 10.1016/j.jacl.2023.02.004. Epub 2023 Feb 22.

Abstract

Background: Individuals with FH develop cardiovascular disease due to lifelong cumulative exposure to elevated LDL-C. Effective screening for FH is not yet established.

Objective: To evaluate the practicability of a FH screening by measuring directly the LDL-C in preschoolers.

Methods: LDL-C measurement through capillary blood sampling during the compulsory routine check-ups by the pediatrician in children aged 2 to 6 years including information on family history as dyslipidemia and/or premature cardiovascular disease in first and second grade of pedigrees.

Results: 15,009 children (52.2% males, median age 3.9 years [IQR 3.0-5.1]) participated in the study. Positive family history for hyperlipidemia was stated in 40.9% cases, in 12.0% also in at least one 1st degree relative. In the total cohort, median LDL-C was 93 mg/dL [IQR 79-109 mg/dL]. Boys had significantly higher LDL-C levels than girls (p < 0.0001), whereas there was no difference regarding their age (p = 0.757). Children from families with a positive history for hypercholesterolemia/dyslipidemia had significantly higher LDL-C levels (p < 0.001) and were more frequently among those with LDL-C values above 135 mg/dL (3.5 mmol/L, 96th percentile; 53.2% vs. 40.3%, p < 0.001) and those with LDL-C levels above 160 mg/dL (4.1 mmol/L, 99th percentile; 45.3% vs. 40.7%, p < 0.001) than children without positive family history.

Conclusions: Direct measurement of LDL-C levels in children at ages 2-6 years during the compulsory routine check-ups as well as at any voluntary visits to the pediatrician's office is practicable and delivers reliable information, which can be used for a FH screening strategy in the general population.

Keywords: Childhood; Direct measurement LDL-C; FH; General population; Screening strategies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cardiovascular Diseases*
  • Child
  • Child, Preschool
  • Cholesterol, LDL
  • Dyslipidemias*
  • Female
  • Humans
  • Hypercholesterolemia*
  • Hyperlipoproteinemia Type II*
  • Male

Substances

  • Cholesterol, LDL